Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in healthy female participants of childbearing potential.

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Abivax

Enrolment target

Start

09 Aug 2023

Age 18 Years to any · Sex: Female

Always speak to your GP or specialist before deciding to take part in a study.